Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RenovoRx, Inc. - Common Stock
(NQ:
RNXT
)
0.9767
-0.0033 (-0.34%)
Streaming Delayed Price
Updated: 10:44 AM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RenovoRx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
RenovoRx CEO Issues Update Letter to Shareholders
May 30, 2024
From
RenovoRx, Inc.
Via
Business Wire
Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery
May 21, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024
May 14, 2024
From
RenovoRx, Inc.
Via
Business Wire
RNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024
↗
May 13, 2024
RNXT stock results show that RenovoRx beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
RNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023
↗
April 08, 2024
RNXT stock results show that RenovoRx met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024
May 02, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement
April 18, 2024
From
RenovoRx , Inc.
Via
Business Wire
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
April 16, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
April 15, 2024
From
RenovoRx, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 09, 2024
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Via
InvestorPlace
RenovoRx Announces $11.1 Million at Market Private Placement
April 08, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
April 05, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
March 12, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Highlights Key Leadership Promotions
March 08, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx CEO Issues Letter to Shareholders
February 06, 2024
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 31, 2024
Via
Benzinga
RenovoRx Closes $6.1 Million Private Placement
January 29, 2024
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 10, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 02, 2024
Shares of Longboard Pharmaceuticals, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
January 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 29, 2023
Via
Benzinga
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
December 28, 2023
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
Via
Benzinga
Clinical Trials at Major University; New Application Targeting Tumors with an IP Portfolio of 9 Patents Issued, 9 Pending for Cancer Treatments Partnered with Imugene: RenovoRx (NASDAQ: RNXT)
December 28, 2023
Via
Get News
Topics
Intellectual Property
RenovoRx (NASDAQ: RNXT) Elevates IP Portfolio with New Application and Advances Cancer Treatments in Phase 3 Clinical Trials
December 21, 2023
Via
Get News
Topics
Intellectual Property
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
December 21, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
December 19, 2023
From
RenovoRx, Inc.
Via
Business Wire
Biopharma Company Issues New Patent Application Adding to Strong IP Portfolio of 9 Patents Issued and 9 Pending; Phase 3 Clinical Trials for Cancer Treatments in Collaboration with Imugene: RenovoRx (NASDAQ: RNXT) $RNXT
December 19, 2023
Via
Viz Release
Topics
Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 14, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
